As of 2026-02-13, the EV/EBITDA ratio of agilon health Inc (AGL) is -0.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 149.52 mil USD. AGL's TTM EBITDA according to its financial statements is -312.53 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 13.3x | 12.1x |
| Forward P/E multiples | 11.6x - 13.1x | 12.6x |
| Fair Price | (4.65) - (5.26) | (4.94) |
| Upside | -1323.2% - -1484.8% | -1400.7% |
| Date | EV/EBITDA |
| 2026-02-11 | -0.48 |
| 2026-02-10 | -0.65 |
| 2026-02-09 | -1.05 |
| 2026-02-06 | -1.12 |
| 2026-02-05 | -1.08 |
| 2026-02-04 | -1.22 |
| 2026-02-03 | -1.40 |
| 2026-02-02 | -1.56 |
| 2026-01-30 | -1.57 |
| 2026-01-29 | -1.64 |
| 2026-01-28 | -1.54 |
| 2026-01-27 | -1.62 |
| 2026-01-26 | -1.85 |
| 2026-01-23 | -1.95 |
| 2026-01-22 | -2.00 |
| 2026-01-21 | -1.86 |
| 2026-01-20 | -1.92 |
| 2026-01-16 | -2.02 |
| 2026-01-15 | -2.02 |
| 2026-01-14 | -1.90 |
| 2026-01-13 | -1.85 |
| 2026-01-12 | -1.94 |
| 2026-01-09 | -1.95 |
| 2026-01-08 | -1.74 |
| 2026-01-07 | -1.44 |
| 2026-01-06 | -1.53 |
| 2026-01-05 | -1.23 |
| 2026-01-02 | -1.19 |
| 2025-12-31 | -1.22 |
| 2025-12-30 | -1.29 |
| 2025-12-29 | -1.34 |
| 2025-12-26 | -1.31 |
| 2025-12-24 | -1.25 |
| 2025-12-23 | -1.22 |
| 2025-12-22 | -1.29 |
| 2025-12-19 | -1.33 |
| 2025-12-18 | -1.25 |
| 2025-12-17 | -1.18 |
| 2025-12-16 | -1.17 |
| 2025-12-15 | -1.16 |
| 2025-12-12 | -1.30 |
| 2025-12-11 | -1.30 |
| 2025-12-10 | -1.19 |
| 2025-12-09 | -1.15 |
| 2025-12-08 | -1.24 |
| 2025-12-05 | -1.13 |
| 2025-12-04 | -1.32 |
| 2025-12-03 | -1.20 |
| 2025-12-02 | -1.15 |
| 2025-12-01 | -1.06 |